Falke LL - Search Results

1

Nephronophthisis-associated CEP164 regulates cell cycle progression, apoptosis and epithelial-to-mesenchymal transition.

Slaats GG, Ghosh AK, Falke LL, Le Corre S, Shaltiel IA, van de Hoek G, Klasson TD, Stokman MF, Logister I, Verhaar MC, Goldschmeding R, Nguyen TQ, Drummond IA, Hildebrandt F, Giles RH. Slaats GG, et al. Among authors: falke ll. PLoS Genet. 2014 Oct 23;10(10):e1004594. doi: 10.1371/journal.pgen.1004594. eCollection 2014 Oct. PLoS Genet. 2014. PMID: 25340510 Free PMC article.

2

A perspective on anti-CCN2 therapy for chronic kidney disease.

Falke LL, Goldschmeding R, Nguyen TQ. Falke LL, et al. Nephrol Dial Transplant. 2014 Feb;29 Suppl 1:i30-i37. doi: 10.1093/ndt/gft430. Nephrol Dial Transplant. 2014. PMID: 24493868 Review.

3

Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis.

Kinashi H, Falke LL, Nguyen TQ, Bovenschen N, Aten J, Leask A, Ito Y, Goldschmeding R. Kinashi H, et al. Among authors: falke ll. Kidney Int. 2017 Oct;92(4):850-863. doi: 10.1016/j.kint.2017.03.029. Epub 2017 May 23. Kidney Int. 2017. PMID: 28545716 Free article.

4

Diverse origins of the myofibroblast—implications for kidney fibrosis.

Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Falke LL, et al. Nat Rev Nephrol. 2015 Apr;11(4):233-44. doi: 10.1038/nrneph.2014.246. Epub 2015 Jan 13. Nat Rev Nephrol. 2015. PMID: 25584804 Review.

5

Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Kok HM, Falke LL, Goldschmeding R, Nguyen TQ. Kok HM, et al. Among authors: falke ll. Nat Rev Nephrol. 2014 Dec;10(12):700-11. doi: 10.1038/nrneph.2014.184. Epub 2014 Oct 14. Nat Rev Nephrol. 2014. PMID: 25311535 Review.

6

Age-dependent shifts in renal response to injury relate to altered BMP6/CTGF expression and signaling.

Falke LL, Kinashi H, Dendooven A, Broekhuizen R, Stoop R, Joles JA, Nguyen TQ, Goldschmeding R. Falke LL, et al. Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F926-F934. doi: 10.1152/ajprenal.00324.2016. Epub 2016 Aug 24. Am J Physiol Renal Physiol. 2016. PMID: 27558559 Free article.

7

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.

Knoppert SN, Valentijn FA, Nguyen TQ, Goldschmeding R, Falke LL. Knoppert SN, et al. Among authors: falke ll. Front Pharmacol. 2019 Jul 12;10:770. doi: 10.3389/fphar.2019.00770. eCollection 2019. Front Pharmacol. 2019. PMID: 31354486 Free PMC article. Review.

8

Cellular senescence in the aging and diseased kidney.

Valentijn FA, Falke LL, Nguyen TQ, Goldschmeding R. Valentijn FA, et al. Among authors: falke ll. J Cell Commun Signal. 2018 Mar;12(1):69-82. doi: 10.1007/s12079-017-0434-2. Epub 2017 Dec 19. J Cell Commun Signal. 2018. PMID: 29260442 Free PMC article. Review.

9

Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney.

Falke LL, Dendooven A, Leeuwis JW, Nguyen TQ, van Geest RJ, van der Giezen DM, Broekhuizen R, Lyons K, Stoop R, Kemperman H, Schlingemann R, Joles JA, Goldschmeding R. Falke LL, et al. Matrix Biol. 2012 Sep-Oct;31(7-8):421-31. doi: 10.1016/j.matbio.2012.06.002. Matrix Biol. 2012. PMID: 23199377

10

Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study.

Gerritsen KG, Falke LL, van Vuuren SH, Leeuwis JW, Broekhuizen R, Nguyen TQ, de Borst GJ, Nathoe HM, Verhaar MC, Kok RJ, Goldschmeding R, Visseren FL; SMART Study Group. Gerritsen KG, et al. Among authors: falke ll. Growth Factors. 2016 Aug;34(3-4):149-58. doi: 10.1080/08977194.2016.1210142. Growth Factors. 2016. PMID: 27686612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters